The plasma half-life of GLP-1 is short, so GLP-1 receptor agonists (RAs) have modifications in the peptide to prolong half-life.6 As these incretin hormones are degraded by dipeptidyl peptidase-4 (DPP-4), DPP-4 inhibitors can amplify their pharmacological actions.8 Both of these two incretin-based therapies improve postprandial glucose control.6,8 Among the three drug classes, the preferred second-line treatment remains unclear ( Table 1 )
Red cell metabolism, a manual of biochemical methods
LDH (lactose dehydrogenase): The optimal range is 140 to 180
Acetylsalicylic acid (ASA) and NSAIDs inhibit the COX site, whereas acetaminophen inhibits the peroxidase site
Characterisation of basal resistance (BR) by expression patterns of newly isolated representative genes in tobacco
Research shows promising results for skin lightening and antioxidant support, though long-term effects need further study